Integrated financials for the second quarter and half year ended 30 September 2025.
SHILPAMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shilpa Medicare Limited has filed its integrated unaudited financial results for the second quarter and half year ended 30 September 2025 with the stock exchanges. This is a routine quarterly disclosure combining the standalone and consolidated performance of the company. The specific revenue, profit, and margin figures would need to be reviewed in the actual results document. The filing covers both standalone and consolidated numbers under Ind AS for the July-September 2025 quarter and the six-month period.
As a routine quarterly results filing, this announcement is informational and its stock impact will depend on the actual reported numbers versus market expectations. Investors should review the detailed financials for revenue growth, margin trends, and segment performance.